SCHEMBL35850

SCHEMBL35850

CC(=CN)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35849 1.00
SCHEMBL13912575 1.00
Ammonia Solution, Strong SCHEMBL3422173 0.97
Hydrochloric Acid SCHEMBL21681696 0.97
Hydrochloric Acid SCHEMBL21681694 0.97
Hydrochloric Acid SCHEMBL23422124 0.94
Butane SCHEMBL3945356 0.89 ALOX15 (0.34)
Butane SCHEMBL23608041 0.89 ALOX15 (0.34)
Methacrylic Acid SCHEMBL4887479 0.89 TDP1 (0.41)
Methacrylic Acid SCHEMBL28921733 0.89 TDP1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4349 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3782614-B1 MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF IMPAX LABORATORIES LLC (US) 2026-05-20 EP claimed
EP-3873394-B1 SYSTEM FOR ANALYSIS OF BODY FLUIDS AND WOUND-ASSOCIATED BIOMOLECULES PROGENITEC INC (US) 2025-12-24 EP claimed
EP-4642442-A1 CONTROLLED-RELEASE ORAL FORMULATIONS OF LIPOPHILIC DRUGS BSD Science Ltd. (IL) 2025-11-05 EP claimed
EP-3943071-B1 COMPOSITION COMPRISING NATURAL LIPOPHILIC COMPOUNDS, USE OF THE COMPOSITION AND METHOD FOR PREPARING THE COMPOSITION KHINIKADZE ZURAB DURMISCHCHANOWITCH (RU) 2025-06-18 EP claimed
CN-119912627-A Preparation method of viscosity index improver of automatic gearbox oil 新乡市瑞丰新材料股份有限公司 2025-05-02 CN claimed
WO-2025088604-A1 COMPOSITION CONTAINING POLYELECTROLYTE SOLUTION AND POLYCATIONIC RHEOLOGY MODIFIER ADAMA AGAN LTD. (IL) 2025-05-01 WO claimed
WO-2025036941-A1 ORAL PHARMACEUTICAL DOSAGE FORM PROVIDING IMMEDIATE RELEASE OF VIDOFLUDIMUS IMMUNIC AG (DE) 2025-02-20 WO claimed
WO-2025036938-A1 ORAL PHARMACEUTICAL DOSAGE FORM PROVIDING IMMEDIATE RELEASE OF VIDOFLUDIMUS IMMUNIC AG (DE) 2025-02-20 WO claimed
EP-4049660-B1 DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE HOFFMANN LA ROCHE (CH) 2025-02-19 EP claimed
CN-119421704-A Pharmaceutical composition of tricyclic AKR1C 3-dependent KARS inhibitor and preparation method thereof 诺华股份有限公司 2025-02-11 CN claimed
US-4710281-A AUTOMOBILE PAINT COMPRISING A NEUTRALIZED POLYMER HAVING AMINO AND HYDROXY PENDANT GROUPS AND A (METH)ACRYLOYLOXYALKYLENEPHENYLENE ALKANE AKZO NV (NL) 1987-12-01 US claimed
US-4661223-A BINDER OBTAINED BY POLYMERIZATION IN PRESENCE OF ETHYLENICALLY UNSATURATED POLYESTER AKZO NV (NL) 1987-04-28 US claimed
EP-0104683-B1 PROCESS FOR COATING AN ELECTRICALLY CONDUCTIVE SUBSTRATE AND AN AQUEOUS COMPOSITION CONTAINING A CATIONIC BINDER AKZO N.V. (NL) 1986-09-10 EP claimed
EP-0152955-A2 Porous water-treating material and process for producing the same MITSUBISHI RAYON CO., LTD. (JP) 1985-08-28 EP claimed
EP-0130680-A2 Cure to elastomers composition LOCTITE CORPORATION (US) 1985-01-09 EP claimed
US-4447582-A QUATERNIZATION, CROSSLINKING COPOLYMER RUBBER & CHEMICAL CORPORATION (US) 1984-05-08 US claimed
US-4439600-A Cure to elastomers compositions LOCTITE CORPORATION (US) 1984-03-27 US claimed
US-4132656-A OLEFIN-DIALKYLAMINOALKYL METHACRYLATE POLYMER; OR ALKYL METHACRYLATE-DIALKYLAMINOALKYL METHACRYLATE OR N(ALKANONE) ACRYLAMIDE POLYMER AS ANTIDEPOSIT AGENT ATLANTIC RICHFIELD COMPANY (US) 1979-01-02 US claimed
US-4076691-A Polyacrylates containing primary amino groups CESKOSLOVENSKA AKADEMIE VED (CS) 1978-02-28 US claimed
US-4026836-A AMINOMETHACRYLATE SALT CATALYST, REACTING A POLYETHER OR POLYESTER WITH AN AROMATIC POLYISOCYANURATE TEXACO DEVELOPMENT CORPORATION (US) 1977-05-31 US claimed